Login / Signup

Predicting the Risk of nOdal disease with histological and Molecular features in Endometrial cancer: the prospective PROME trial.

Giorgio BoganiLuca LalliJvan CasarinFabio GhezziValentina ChiappaFrancesco FanfaniGiovanni ScambiaFrancesco Raspagliesi
Published in: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society (2024)
NCT05793333.
Keyphrases
  • endometrial cancer
  • study protocol
  • phase iii
  • clinical trial
  • phase ii
  • neoadjuvant chemotherapy
  • randomized controlled trial
  • squamous cell carcinoma
  • single molecule
  • open label
  • double blind